tiprankstipranks
Stryker Corporation (MX:SYK)
:SYK
Mexico Market
SYK
Stryker
RESEARCH TOOLSreports

Stryker (SYK) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

SYK Analyst Ratings

Strong Buy
18Ratings
Strong Buy
16 Buy
2 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Stryker
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SYK Stock 12 Month Forecast

Average Price Target

$6,341.28
▲(15.21% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $6,341.28 with a high forecast of $7,686.85 and a low forecast of $5,355.45. The average price target represents a 15.21% change from the last price of $5,504.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5326":"$5,326","7687":"$7,687","5916.25":"$5,916.3","6506.5":"$6,506.5","7096.75":"$7,096.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7686.84957495,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6341.278233711178,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5355.45344013,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.36K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5326,5916.25,6506.5,7096.75,7687],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5568.24,5731.209967303846,5894.179934607692,6057.149901911538,6220.119869215385,6383.089836519231,6546.059803823076,6709.029771126923,6871.999738430769,7034.969705734615,7197.9396730384615,7360.909640342307,7523.879607646153,{"y":7686.84957495,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5568.24,5627.704479516245,5687.168959032489,5746.6334385487335,5806.097918064977,5865.562397581222,5925.026877097466,5984.491356613711,6043.955836129955,6103.4203156462,6162.884795162444,6222.349274678689,6281.813754194933,{"y":6341.278233711178,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5568.24,5551.871803086923,5535.503606173846,5519.135409260769,5502.767212347692,5486.399015434615,5470.030818521538,5453.662621608461,5437.294424695385,5420.926227782307,5404.558030869231,5388.189833956154,5371.821637043076,{"y":5355.45344013,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7220.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6618.1,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6654.614,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6707.401,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6365.651,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6342.068,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6424.197,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5848.126,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5694.814,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5327.903,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5463,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5676.7,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5568.24,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$7,687Average Price Target$6,341Lowest Price Target$5,355
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on MX:SYK
Joanne Wuensch
Citi
Citi
$6,740.78→$6,081.9
Buy
10.50%
Upside
Reiterated
09/10/26
Stryker price target lowered to $360 from $399 at CitiStryker price target lowered to $360 from $399 at Citi
William Blair Analyst forecast on MX:SYK
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
09/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on MX:SYK
Larry Biegelsen
Wells Fargo
Wells Fargo
$7,061.77→$5,879.17
Buy
6.82%
Upside
Assigned
09/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Stryker (NYSE: SYK), CVS Health (NYSE: CVS) and Biogen (NASDAQ: BIIB)
BMO Capital Analyst forecast on MX:SYK
Vik Chopra
BMO Capital
BMO Capital
$6,233.95→$5,355.45
Buy
-2.70%
Downside
Reiterated
09/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY), Stryker (NYSE: SYK) and InnovAge Holding (NASDAQ: INNV)
BTIG Analyst forecast on MX:SYK
Ryan Zimmerman
BTIG
BTIG
$6,048.11
Buy
9.89%
Upside
Reiterated
08/27/26
Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (NASDAQ: CNTB) and Stryker (NYSE: SYK)
Bank of America Securities Analyst forecast on MX:SYK
Travis Steed
Bank of America Securities
Bank of America Securities
$337.88→$6,419.79
Buy
16.64%
Upside
Reiterated
08/11/26
Bank of America Securities Sticks to Its Buy Rating for Stryker (SYK)
J.P. Morgan Analyst forecast on MX:SYK
Robbie Marcus
J.P. Morgan
J.P. Morgan
$5,912.96
Buy
7.43%
Upside
Reiterated
08/04/26
Stryker (SYK) Receives a Buy from J.P. Morgan
Citizens JMP Analyst forecast on MX:SYK
David Turkaly
Citizens JMP
Citizens JMP
$7,433.44→$6,757.67
Buy
22.78%
Upside
Reiterated
08/03/26
Stryker price target lowered to $400 from $440 at CitizensStryker price target lowered to $400 from $440 at Citizens
Raymond James Analyst forecast on MX:SYK
Jayson Bedford
Raymond James
Raymond James
$6,470.47→$6,250.84
Buy
13.57%
Upside
Reiterated
07/31/26
Stryker price target lowered to $370 from $383 at Raymond JamesStryker price target lowered to $370 from $383 at Raymond James
Needham Analyst forecast on MX:SYK
Michael Matson
Needham
Needham
$7,061.77
Buy
28.30%
Upside
Reiterated
07/31/26
Analysts Conflicted on These Healthcare Names: Roivant Sciences (NASDAQ: ROIV), Neurocrine (NASDAQ: NBIX) and Stryker (NYSE: SYK)
Truist Financial Analyst forecast on MX:SYK
Richard Newitter
Truist Financial
Truist Financial
$5,575.08→$5,744.02
Hold
4.36%
Upside
Reiterated
07/31/26
Truist Financial Sticks to Its Hold Rating for Stryker (SYK)
TD Cowen Analyst forecast on MX:SYK
Mathew Blackman
TD Cowen
TD Cowen
$5,997.43
Hold
8.96%
Upside
Assigned
07/31/26
Analysts Conflicted on These Healthcare Names: Alnylam Pharma (NASDAQ: ALNY), Stryker (NYSE: SYK) and Bicycle Therapeutics (NASDAQ: BCYC)
RBC Capital Analyst forecast on MX:SYK
Kendall Au
RBC Capital
RBC Capital
$7,348.97→$7,095.55
Buy
28.92%
Upside
Reiterated
07/31/26
Stryker (SYK) Receives a Buy from RBC Capital
Piper Sandler Analyst forecast on MX:SYK
Matthew O'Brien
Piper Sandler
Piper Sandler
$7,095.55→$6,588.73
Buy
19.71%
Upside
Reiterated
07/31/26
Piper Sandler Remains a Buy on Stryker (SYK)
UBS Analyst forecast on MX:SYK
Patrick Wood
UBS
UBS
$6,419.79→$6,757.67
Buy
22.78%
Upside
Upgraded
07/28/26
Analysts Are Bullish on These Healthcare Stocks: The Ensign Group (ENSG), Stryker (SYK)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on MX:SYK
Joanne Wuensch
Citi
Citi
$6,740.78→$6,081.9
Buy
10.50%
Upside
Reiterated
09/10/26
Stryker price target lowered to $360 from $399 at CitiStryker price target lowered to $360 from $399 at Citi
William Blair Analyst forecast on MX:SYK
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
09/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on MX:SYK
Larry Biegelsen
Wells Fargo
Wells Fargo
$7,061.77→$5,879.17
Buy
6.82%
Upside
Assigned
09/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Stryker (NYSE: SYK), CVS Health (NYSE: CVS) and Biogen (NASDAQ: BIIB)
BMO Capital Analyst forecast on MX:SYK
Vik Chopra
BMO Capital
BMO Capital
$6,233.95→$5,355.45
Buy
-2.70%
Downside
Reiterated
09/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY), Stryker (NYSE: SYK) and InnovAge Holding (NASDAQ: INNV)
BTIG Analyst forecast on MX:SYK
Ryan Zimmerman
BTIG
BTIG
$6,048.11
Buy
9.89%
Upside
Reiterated
08/27/26
Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (NASDAQ: CNTB) and Stryker (NYSE: SYK)
Bank of America Securities Analyst forecast on MX:SYK
Travis Steed
Bank of America Securities
Bank of America Securities
$337.88→$6,419.79
Buy
16.64%
Upside
Reiterated
08/11/26
Bank of America Securities Sticks to Its Buy Rating for Stryker (SYK)
J.P. Morgan Analyst forecast on MX:SYK
Robbie Marcus
J.P. Morgan
J.P. Morgan
$5,912.96
Buy
7.43%
Upside
Reiterated
08/04/26
Stryker (SYK) Receives a Buy from J.P. Morgan
Citizens JMP Analyst forecast on MX:SYK
David Turkaly
Citizens JMP
Citizens JMP
$7,433.44→$6,757.67
Buy
22.78%
Upside
Reiterated
08/03/26
Stryker price target lowered to $400 from $440 at CitizensStryker price target lowered to $400 from $440 at Citizens
Raymond James Analyst forecast on MX:SYK
Jayson Bedford
Raymond James
Raymond James
$6,470.47→$6,250.84
Buy
13.57%
Upside
Reiterated
07/31/26
Stryker price target lowered to $370 from $383 at Raymond JamesStryker price target lowered to $370 from $383 at Raymond James
Needham Analyst forecast on MX:SYK
Michael Matson
Needham
Needham
$7,061.77
Buy
28.30%
Upside
Reiterated
07/31/26
Analysts Conflicted on These Healthcare Names: Roivant Sciences (NASDAQ: ROIV), Neurocrine (NASDAQ: NBIX) and Stryker (NYSE: SYK)
Truist Financial Analyst forecast on MX:SYK
Richard Newitter
Truist Financial
Truist Financial
$5,575.08→$5,744.02
Hold
4.36%
Upside
Reiterated
07/31/26
Truist Financial Sticks to Its Hold Rating for Stryker (SYK)
TD Cowen Analyst forecast on MX:SYK
Mathew Blackman
TD Cowen
TD Cowen
$5,997.43
Hold
8.96%
Upside
Assigned
07/31/26
Analysts Conflicted on These Healthcare Names: Alnylam Pharma (NASDAQ: ALNY), Stryker (NYSE: SYK) and Bicycle Therapeutics (NASDAQ: BCYC)
RBC Capital Analyst forecast on MX:SYK
Kendall Au
RBC Capital
RBC Capital
$7,348.97→$7,095.55
Buy
28.92%
Upside
Reiterated
07/31/26
Stryker (SYK) Receives a Buy from RBC Capital
Piper Sandler Analyst forecast on MX:SYK
Matthew O'Brien
Piper Sandler
Piper Sandler
$7,095.55→$6,588.73
Buy
19.71%
Upside
Reiterated
07/31/26
Piper Sandler Remains a Buy on Stryker (SYK)
UBS Analyst forecast on MX:SYK
Patrick Wood
UBS
UBS
$6,419.79→$6,757.67
Buy
22.78%
Upside
Upgraded
07/28/26
Analysts Are Bullish on These Healthcare Stocks: The Ensign Group (ENSG), Stryker (SYK)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
STOKStoke Therapeutics
AXGNAxoGen
JAZZJazz Pharmaceuticals
PTGXProtagonist Therapeutics
CABACabaletta Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Stryker

3 Months
Robbie MarcusJ.P. Morgan
Success Rate
14/19 ratings generated profit
74%
Average Return
+2.43%
Copying Robbie Marcus's trades and holding each position for 3 Months would result in 73.68% of your transactions generating a profit, with an average return of +2.43% per trade.
1 Year
Matt MiksicBarclays
Success Rate
21/31 ratings generated profit
68%
Average Return
+9.53%
Copying Matt Miksic's trades and holding each position for 1 Year would result in 67.74% of your transactions generating a profit, with an average return of +9.53% per trade.
2 Years
Jeff JohnsonRobert W. Baird
Success Rate
24/30 ratings generated profit
80%
Average Return
+16.68%
Copying Jeff Johnson's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +16.68% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SYK Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
1
1
1
0
0
Buy
37
26
36
26
28
Hold
8
6
6
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
46
33
43
28
30
In the current month, SYK has received 28 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. SYK average Analyst price target in the past 3 months is 6,341.28.
Each month's total comprises the sum of three months' worth of ratings.

SYK Financial Forecast

SYK Earnings Forecast

Next quarter’s earnings estimate for SYK is $60.46 with a range of $58.12 to $64.18. The previous quarter’s EPS was $62.34. SYK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.
Next quarter’s earnings estimate for SYK is $60.46 with a range of $58.12 to $64.18. The previous quarter’s EPS was $62.34. SYK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.

SYK Sales Forecast

Next quarter’s sales forecast for SYK is $112.74B with a range of $111.35B to $113.58B. The previous quarter’s sales results were $111.32B. SYK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.
Next quarter’s sales forecast for SYK is $112.74B with a range of $111.35B to $113.58B. The previous quarter’s sales results were $111.32B. SYK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.

SYK Stock Forecast FAQ

What is MX:SYK’s average 12-month price target, according to analysts?
Based on analyst ratings, Stryker Corporation’s 12-month average price target is 6,341.28.
    What is MX:SYK’s upside potential, based on the analysts’ average price target?
    Stryker Corporation has 15.21% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Stryker Corporation a Buy, Sell or Hold?
          Stryker Corporation has a consensus rating of Strong Buy, which is based on 16 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Stryker Corporation’s share price target?
            The average share price target for Stryker Corporation is 6,341.28. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $7,686.85 ,and the lowest forecast is $5,355.45. The average share price target represents 15.21% Increase from the current price of $5,504.
              What do analysts say about Stryker Corporation?
              Stryker Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of Stryker Corporation?
                To buy shares of MX:SYK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.